BHC:NYSE, Bausch Health Companies Inc.

BHC stock overview

Bausch Health Companies Inc. (BHC:NYSE) closed at $8.56 on November 19, 2026, down 1.95% on the day. The stock trades 5.3% below its 52-week high of $9.04 and 97.7% above its 52-week low of $4.33. Over the past year, it gained 42.7%. Bausch Health Companies Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$8.56
Day change
-1.95%
Volume
3,263,799
Average volume
3,146,496
Market cap
3B+
52-week range
$4.33 – $9.04
50-day average
$6.70
200-day average
$5.84

Price action over the past year

In 252 trading sessions since November 19, 2025, BHC closed higher on 125 days (50%). Its best day was July 30, 2026 (+28.85%) and its worst was January 23, 2026 (-10.05%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

BHC news

About Bausch Health Companies Inc.

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Similar stocks

Find more stocks like BHC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.